Mfn Partners Management, LP Evolus, Inc. Transaction History

Mfn Partners Management, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$3.03 - $5.48 $4.3 Million - $7.78 Million	-1,420,000 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$3.53 - $12.21 $4.59 Million - $15.9 Million	1,300,000 Added 1083.33%	1,420,000 $5.89 Million
Q2 2019 Aug 14, 2019	BUY	$13.19 - $28.36 $1.58 Million - $3.4 Million	120,000 New	120,000 $1.75 Million

169

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $708M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Mfn Partners Management, LP, based on Form 13F filings with the SEC.

Stay updated on Mfn Partners Management, LP with notifications on news.